Avid Bioservices (CDMO) Financials

$12.49

$0.00 (0.00%)

As on 06-Feb-2025 09:30EDT

Market cap

$799 Mln

Revenue (TTM)

$150 Mln

P/E Ratio

--

P/B Ratio

17.8

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Apr-24	Apr-23	Apr-22	Apr-21	Apr-20	Apr-19	Apr-18	Apr-17	Apr-16	Apr-15
Operating Revenue	150.45	139.91	149.27	119.60	95.87	59.70
Cost of Revenue	138.89	132.59	117.79	82.95	66.56	55.77
Gross Profit	11.55	7.32	31.48	36.65	29.31	3.93
Operating Expenses	31.93	26.00	27.88	21.23	17.06	14.52
Operating Profit (EBIT)	-20.38	-18.68	-2.61	10.86	8.92	-10.59
Other Income	--	--	1.00	-0.08	0.13	0.47
Profit before Tax	-35.23	-26.93	2.00	12.66	11.21	-10.47
Provision for Tax	116.72	113.83	1.44	-115.01	-2.29	-3.21
Profit after Tax (Net Income)	-152.05	-140.75	0.56	127.67	11.21	-7.26
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	0.56	127.67	3.32	-15.15

Liabilities ($ Mln)	TTM	Apr-24	Apr-23	Apr-22	Apr-21	Apr-20	Apr-19	Apr-18	Apr-17	Apr-16	Apr-15
Shareholder's Funds	44.81	60.89	189.47	174.53	77.74	41.90
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	204.52	205.10	187.88	179.56	116.84	21.24
Current Liabilities	74.16	70.57	73.71	75.76	70.94	44.48
Total Liabilities	397.64	336.56	451.05	429.84	265.51	107.62

Assets ($ Mln)	TTM	Apr-24	Apr-23	Apr-22	Apr-21	Apr-20	Apr-19	Apr-18	Apr-17	Apr-16	Apr-15
Non-Current Assets	226.98	232.56	338.60	249.82	57.71	47.86
Current Assets	96.51	104.00	112.45	180.02	207.80	59.76
Total Assets	397.64	336.56	451.05	429.84	265.51	107.62
Total Debt*	205.53	207.83	189.23	182.53	118.19	26.85
Net Current Assets	22.35	33.44	38.74	104.26	136.87	15.28

Cashflow ($ Mln)	TTM	Apr-24	Apr-23	Apr-22	Apr-21	Apr-20	Apr-19	Apr-18	Apr-17	Apr-16	Apr-15
Cash From Operating Activities	--	10.95	-12.89	9.47	31.18	5.83
Cash Flow from Investing Activities	--	--	-77.64	-56.41	-9.86	-3.81
Cash from Financing Activities	--	20.07	2.90	3.20	112.34	1.10
Net Cash Inflow / Outflow	--	--	-87.62	-43.75	133.65	3.11

Financials Ratios	TTM	Apr-24	Apr-23	Apr-22	Apr-21	Apr-20	Apr-19	Apr-18	Apr-17	Apr-16	Apr-15
Adjusted EPS ($)	--	--	--	--	--	--
Cash EPS ($)	--	--	--	--	--	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	--	--	--	--
Free Cash Flow per Share ($)	--	--	--	--	--	--

Profitability Ratios	TTM	Apr-24	Apr-23	Apr-22	Apr-21	Apr-20	Apr-19	Apr-18	Apr-17	Apr-16	Apr-15
ROCE (%)	--	-43.48	0.15	46.18	8.47	-11.57
ROE (%)	-287.71	-112.44	0.31	101.22	18.74	-15.28
ROA (%)	-32.73	-35.74	0.13	36.72	6.01	-7.80
EBIT Margin (%)	-17.75	-16.15	2.48	12.89	12.77	-22.31
Net Margin (%)	-101.07	-100.60	0.37	106.82	11.68	-12.06
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Apr-24	Apr-23	Apr-22	Apr-21	Apr-20	Apr-19	Apr-18	Apr-17	Apr-16	Apr-15
Revenue Growth (%)	6.75	-0.06	0.25	0.25	0.61	0.11
EBIT Growth (%)	-98.94	-710.38	-76.00	25.97	191.91	-136.94
Net Profit Growth (%)	-1,227.95	-25,234.46	-99.56	1,038.71	254.52	-72.15
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	TTM	Apr-24	Apr-23	Apr-22	Apr-21	Apr-20	Apr-19	Apr-18	Apr-17	Apr-16	Apr-15
Price / Earnings	--	--	--	--	--	--
Price / Book Value	17.83	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	107.87	-14.40	13.81	2.83	-3.30	0.92
Close Price ($)	9.96	7.63	18.05	13.46	21.41	6.10
High Price ($)	12.48	18.86	21.05	34.51	22.14	8.38
Low Price ($)	4.07	4.07	11.30	13.43	5.08	3.02
Market Cap ($ Cr)	798.90	--	--	--	--	--

Solvency Ratios	TTM	Apr-24	Apr-23	Apr-22	Apr-21	Apr-20	Apr-19	Apr-18	Apr-17	Apr-16	Apr-15
Debt to Equity	3.44	3.41	1.00	1.05	1.52	0.64
Short term debt to equity ratio	0.06	0.05	0.75	0.02	0.03	0.13
Current Ratio	1.30	1.47	1.53	2.38	2.93	1.34
Quick Ratio	0.92	1.04	0.93	2.03	2.76	1.10
Interest Coverage	-3.19	-5.21	1.42	5.75	10.52	-1,665.13

Operating Efficiency Ratios	TTM	Apr-24	Apr-23	Apr-22	Apr-21	Apr-20	Apr-19	Apr-18	Apr-17	Apr-16	Apr-15
Debtors to sales (%)	20.08	20.73	18.70	21.67	26.03	19.94
Asset Turnover	0.32	0.36	0.34	0.34	0.51	0.64
Receivable days	--	74.29	65.85	77.68	70.22	72.21
Inventory Days	--	102.31	108.49	83.52	62.43	57.11
Payable days	--	62.34	52.87	41.31	41.66	33.66
Cash Conversion Cycle	--	114.27	121.47	119.89	90.99	95.67

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.